SmartAlpha’s Ultrasound AI Software Nerveblox Gains FDA 510(k) Approval
ANKARA, Türkiye, August 18, 2025 — SmartAlpha’s AI-powered software, Nerveblox, designed to assist clinicians performing ultrasound-guided regional anesthesia (“nerve...
Advertisement
TheraBreath Launches Alcohol-Free Fluoride Toothpaste with Clinical Benefits
EWING, N.J., August 19, 2025 — TheraBreath™, the best-selling alcohol-free mouthwash brand in the U.S., has introduced a new...
AbbVie Completes $2.1B Acquisition of Capstan Therapeutics, Advancing In Vivo CAR-T Innovation
NORTH CHICAGO, IL. and SAN DIEGO, CA, August 19, 2025 – AbbVie (NYSE: ABBV) and Capstan Therapeutics, Inc. (“Capstan”),...
Convoke Raises $8.6M Seed Round to Build AI OS for Biopharma
SOUTH SAN FRANCISCO, Calif., August 19, 2025 – Convoke, an AI-native operating system for the biopharmaceutical industry, today announced...
First Patient Dosed in Akeso’s Phase III Trial of Cadonilimab for Resectable Gastric Cancer
Hong Kong, August 20, 2025 — Akeso, Inc. (9926.HK) has announced the enrollment and dosing of the first patient...
FDA Approves Merck Animal Health’s BRAVECTO QUANTUM – First Once-Yearly Injection Flea & Tick Protection for Dogs
July 10, 2025 – The U.S. Food and Drug Administration (FDA) has approved BRAVECTO® QUANTUM (fluralaner for extended-release injectable...
FDA Launches PreCheck Program to Strengthen U.S. Drug Manufacturing
August 7, 2025 – The U.S. Food and Drug Administration (FDA) has announced the launch of FDA PreCheck, a...
IQVIA and Veeva Forge Landmark Global Partnership, Ending Legal Disputes
Research Triangle Park, NC & Pleasanton, CA – August 20, 2025 – After years of high-profile legal battles, life...
Affordable Alternative: Glenmark Announces U.S. Launch of Micafungin for Injection USP
Mahwah, New Jersey, August 19, 2025 – Glenmark Pharmaceuticals Inc., USA is set to introduce Micafungin for Injection USP...
FDA Approves Precigen’s PAPZIMEOS, First Immunotherapy for Recurrent Respiratory Papillomatosis
August 19, 2025 — Germantown, MD – Precigen, Inc. (NASDAQ: PGEN) today announced that the U.S. Food and Drug...
Advertisement
